Paracetamol poisonings up

October 28, 2020

Paracetamol is a popular source of pain relief. In Switzerland, it is available over the counter in 500 milligram tablets, but also in double the dose, in 1,000 milligram (1 gram) tablets when prescribed by a physician. Researchers at ETH Zurich have now investigated whether the availability of the higher-dose tablets could be linked to the increased incidence of paracetamol poisoning, concluding that it is.

Paracetamol is the most widely used painkiller in the world. "It is a very safe drug, but only for short-term pain relief and as long as the daily dosage does not go above the recommended range," says Andrea Burden, Professor of Pharmacoepidemiology at ETH Zurich. For adults, the recommended maximum daily dosage is 4,000 milligrams (4 grams), which equates to a maximum of four of the high-dose tablets or eight of the lower-dose tablets. When overdosed, paracetamol can cause severe poisoning, even resulting in liver failure with fatal outcomes or the need for liver transplantation.

It's important to consult a professional

"One problem with paracetamol is that it is not effective for all patients or against all forms of pain," Burden explains. "If the drug doesn't help to ease someone's symptoms, they may be tempted to increase the dosage without consulting a medical professional. That's the real problem," she says. This is also where the size of the tablets comes into play. It's very easy to exceed the maximum daily dosage by taking just a few extra of the 1,000 milligram tablets, whereas, with the lower-dose 500 milligram tablets, the risk of accidental overdose isn't as great, Burden explains.

Her recommendation is as follows: "We recognize that pain management is challenging, and other medications may have severe adverse effects. But, if paracetamol doesn't have the desired effect, it's important not to simply take more tablets. Instead, people should seek professional medical advice in order to find the best therapeutic option."

Higher-dose tablets sell much better

People in Switzerland have had access to the 1,000 milligram paracetamol tablets since October 2003. Prior to that, the highest available dose was the 500 milligram tablets. Burden and her team analysed sales figures from the Swiss pharmacists' association Pharmasuisse and data from the Tox Info Suisse poison control centre on poisoning cases for the period before and after the higher-dose tablets were launched.

From the sales data, the scientists observed that the 1,000 milligram tablets had rapidly grown in popularity since their introduction. In 2005, the 1,000 milligram tablets outsold the 500 milligram tablets for the first time. Today, sales of the 1,000 milligram tablets are ten times those of the 500 milligram ones.

During the same period, the number of paracetamol poisoning cases reported to Tox Info Suisse had increased. After 2005, there was marked 40 percent increase in poisoning cases within three years, going from 561 cases in 2005 to 786 in 2008. "On that basis, we can conclude that the increased number of poisoning cases is associated with the availability of the 1,000 milligram tablets," says Stefan Weiler, co-author of the study and scientific director of Tox Info Suisse. In the following years, the number of poisoning cases continued to increase, to 1188 in 2018.

Poisonings could be avoided

ETH professor Andrea Burden advocates for a critical review of how the 1,000 milligram tablets are prescribed and dispensed. "At the very least, packs of the 1,000 milligram tablets should contain a smaller number of tablets", she says. As evidence grows that paracetamol is not suitable for chronic pain management, there is little need to have pack-sizes of 40 or 100 tablets. She also says that physicians should prescribe the lower 500 milligram dose, which can be dose adjusted to reach the 1,000 milligrams by taking two tablets when necessary. This could minimize the risk of accidentally exceeding the daily limit.

By reducing the availability of the high-dose formulation, Burden believes that some of the poisoning cases could be avoided. In the meantime, she says pharmacists can help draw attention to the dangers of exceeding the daily maximum when providing these the high-dose tablets to patients.
-end-
Reference

Martinez-De la Torre A, Weiler S, Bräm DS, Allemann SS, Kupferschmidt H, Burden AM: National poison center calls before vs. after availability of high dose acetaminophen (paracetamol) tablets in Switzerland: an interrupted time series analysis. JAMA Network Open, 28 October 2020, doi: 10.1001/jamanetworkopen.2020.22897 [https://doi.org/10.1001/jamanetworkopen.2020.22897]

ETH Zurich

Related Pain Articles from Brightsurf:

Pain researchers get a common language to describe pain
Pain researchers around the world have agreed to classify pain in the mouth, jaw and face according to the same system.

It's not just a pain in the head -- facial pain can be a symptom of headaches too
A new study finds that up to 10% of people with headaches also have facial pain.

New opioid speeds up recovery without increasing pain sensitivity or risk of chronic pain
A new type of non-addictive opioid developed by researchers at Tulane University and the Southeast Louisiana Veterans Health Care System accelerates recovery time from pain compared to morphine without increasing pain sensitivity, according to a new study published in the Journal of Neuroinflammation.

The insular cortex processes pain and drives learning from pain
Neuroscientists at EPFL have discovered an area of the brain, the insular cortex, that processes painful experiences and thereby drives learning from aversive events.

Pain, pain go away: new tools improve students' experience of school-based vaccines
Researchers at the University of Toronto and The Hospital for Sick Children (SickKids) have teamed up with educators, public health practitioners and grade seven students in Ontario to develop and implement a new approach to delivering school-based vaccines that improves student experience.

Pain sensitization increases risk of persistent knee pain
Becoming more sensitive to pain, or pain sensitization, is an important risk factor for developing persistent knee pain in osteoarthritis (OA), according to a new study by researchers from the Université de Montréal (UdeM) School of Rehabilitation and Hôpital Maisonneuve Rosemont Research Centre (CRHMR) in collaboration with researchers at Boston University School of Medicine (BUSM).

Becoming more sensitive to pain increases the risk of knee pain not going away
A new study by researchers in Montreal and Boston looks at the role that pain plays in osteoarthritis, a disease that affects over 300 million adults worldwide.

Pain disruption therapy treats source of chronic back pain
People with treatment-resistant back pain may get significant and lasting relief with dorsal root ganglion (DRG) stimulation therapy, an innovative treatment that short-circuits pain, suggests a study presented at the ANESTHESIOLOGY® 2018 annual meeting.

Sugar pills relieve pain for chronic pain patients
Someday doctors may prescribe sugar pills for certain chronic pain patients based on their brain anatomy and psychology.

Peripheral nerve block provides some with long-lasting pain relief for severe facial pain
A new study has shown that use of peripheral nerve blocks in the treatment of Trigeminal Neuralgia (TGN) may produce long-term pain relief.

Read More: Pain News and Pain Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.